Oct. 13 (Thu.) ,2016 13:30-14:30

Annex Hall
F204

Drug and Drug Discovery

Johnson & Johnson Innovation

Strength & Weakness in the Japanese life-science innovation ecosystem: a venture-capital perspective

In this seminar, leading experts on venture-capital investment will discuss the strengths and weakness of the investment eco-system for early stage life-science innovation in Japan

Cordinator

Jun Kusunoki

Director, New Ventures, Johnson and Johnson INNOVATION

Strength & Weakness in the Japanese life-science innovation ecosystem: a venture-capital perspective

Micheal Flaschen

Vice President, Transaction, Johnson and Johnson INNOVATION

Close Window